Home > Income Statement > AARTI PHARMALABS

AARTI PHARMALABS
Revenue

    Back to Income Statement
AARTI PHARMALABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹2,115 Cr₹1,853 Cr₹1,945 Cr₹1,200 Cr-

What is the latest Revenue of AARTI PHARMALABS ?

The latest Revenue ratio of AARTI PHARMALABS is ₹2,115 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹2,115 Cr
Mar2025₹1,853 Cr
Mar2024₹1,945 Cr
Mar2023₹1,200 Cr
Mar2022-

How is Revenue of AARTI PHARMALABS Trending?

Years Revenue % Change
Mar2026 ₹2,115 Cr
14.17
Mar2025 ₹1,853 Cr
-4.76
Mar2024 ₹1,945 Cr
62.11
Mar2023 ₹1,200 Cr
0
Mar2022 - -

Compare Revenue of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹8,013.8 Cr 8.7% 8.2% -7.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,437.0 Cr -0.5% -3% 16% Stock Analytics
DIVIS LABORATORIES ₹248,054.0 Cr 1.6% 9.3% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,842.0 Cr 3.5% 2.3% 40.6% Stock Analytics
CIPLA ₹111,565.0 Cr 1.6% -3.2% -11.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,163.0 Cr 5.8% 3.2% -8.3% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

8.7%

8.2%

-7.1%

SENSEX

0.7%

-3.9%

-8.9%


You may also like the below Video Courses